Astra Zeneca
Adjust font size:
Manufacturing News, Source : The Manufacturer
Published : 14 May 2007 12:42
Free whitepapers: Achieve Lean Success |
Supply Chain Solutions
PHARMACEUTICAL: Deal
Anglo-Swedish drugs maker, AstraZeneca, has reached a deal to buy MedImmune, a US biotech company. The £7.8 billion cash deal should boost AstraZeneca’s new product pipeline following a series of high profile failures of drugs in the late stage of development last year.
MedImmune is expected fit well with Cambridge Antibody Technology, acquired last August by AstraZeneca for £580 million, and will boost the company’s presence in biotech medicines.
Comments on this story
click here to add a comment
You must be registered & logged in to add comments
already have an account and just want to login?
Manufacturing is to begin again at Fort Dunlop
MANUFACTURING: Refurbished landmark industrial...
more…
McCain’s is to migrate to wind power
FOOD: Turbines to provide over half annual power...
more…
New president of the SBAC defends the right to fly
AEROSPACE: Entering a defining period where...
more…
Sheffield Forgemasters
Sheffield Forgemasters is to give its 700-strong...
more…
SSL International
SSL International, which manufactures Durex...
more…
Want to place a job here? For more information, please contact
no comments yet...